Načítá se...
The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma
The introduction of targeted therapies over the past 10 years revolutionized the treatment of metastatic renal cell carcinoma (mRCC). The next 10 years hold promise for even greater expansion of the therapeutic armamentarium for mRCC. A number of recently completed and ongoing trials have explored t...
Uloženo v:
| Vydáno v: | Can Urol Assoc J |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Canadian Medical Association
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215305/ https://ncbi.nlm.nih.gov/pubmed/28096940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.4294 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|